Since H-Ras is known to down-regulate survivin [17] and Delta-Ex3 has a role in angiogenesis [12], this work is then set to explore potential interactions between Delta-Ex3 and H-Ras in order to design apoptotic-based and angiogenesis-based anti-cancer drugs. This evidence concerns the gene HRAS and cancer.